These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 38173102)

  • 1. [Diagnostic Value of American Thyroid Association Guidelines,American College of Radiology Thyroid Imaging Reporting and Data System,and Chinese Thyroid Imaging Reporting and Data System Alone and Combined With BRAF
    Lin Y; Luo YK; Li J; Ren XY; Wang HW
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Dec; 45(6):921-928. PubMed ID: 38173102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An economically efficient strategy for diagnosing atypia of undetermined significance or follicular lesion of undetermined significance thyroid nodules with ultrasound-based risk stratification systems and
    Ma X; Huang Y; Shen R; Cui Y; Kang Y; Yu J; Cui K
    Quant Imaging Med Surg; 2024 Jan; 14(1):920-931. PubMed ID: 38223096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combination of BRAF
    Li Q; Yang L; Lv J; Xu L; Zhang M; Li S
    Endocrine; 2022 Dec; 78(3):507-516. PubMed ID: 36152114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Performance of Ultrasound Patterns by K-TIRADS and 2015 ATA Guidelines in Risk Stratification of Thyroid Nodules and Follicular Lesions of Undetermined Significance.
    Hong HS; Lee JY
    AJR Am J Roentgenol; 2019 Aug; 213(2):444-450. PubMed ID: 31039023
    [No Abstract]   [Full Text] [Related]  

  • 5. Utility of Six Ultrasound-Based Risk Stratification Systems in the Diagnosis of AUS/FLUS Thyroid Nodules.
    Li Q; Yang L; Yang L; Jiang X; Li S
    Acad Radiol; 2024 Jan; 31(1):131-141. PubMed ID: 37225530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Clinical Usefulness of BRAFV600E Mutation Analysis of Core-Needle Biopsy Specimens in Thyroid Nodules with Previous Atypia of Undetermined Significance or Follicular Lesions of Undetermined Significance Results.
    Choi SH; Baek JH; Lee JH; Choi YJ; Song DE; Chung KW; Kim TY; Shong YK
    Thyroid; 2015 Aug; 25(8):897-903. PubMed ID: 25978151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Stratification of Thyroid Nodules With Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance (AUS/FLUS) Cytology Using Ultrasonography Patterns Defined by the 2015 ATA Guidelines.
    Lee JH; Han K; Kim EK; Moon HJ; Yoon JH; Park VY; Kwak JY
    Ann Otol Rhinol Laryngol; 2017 Sep; 126(9):625-633. PubMed ID: 28719972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. American College of Radiology thyroid imaging report and data system combined with K-RAS mutation improves the management of cytologically indeterminate thyroid nodules.
    Wu H; Zhang B; Cai G; Li J; Gu X
    PLoS One; 2019; 14(7):e0219383. PubMed ID: 31295281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of thyroid nodules characterized as atypia of undetermined significance or follicular lesion of undetermined significance and correlation with Ultrasound features and BRAF(V600E) mutation analysis.
    Jeong SH; Hong HS; Lee EH; Cha JG; Park JS; Kwak JJ
    AJR Am J Roentgenol; 2013 Dec; 201(6):W854-60. PubMed ID: 24261392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Combined Use of Fine-Needle Aspiration (FNA) and BRAF V600E Gene Testing: Can it Increase the Definitive Diagnosis Rate of Nodules Categorized as Bethesda III for Papillary Thyroid Carcinoma?
    Lei L; Hong Qing S; Wei L; Ma Mo Yang F; Xiao Xiang Y
    Am Surg; 2024 Dec; 90(12):3209-3215. PubMed ID: 39047144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prediction of malignant risk in the category "atypia of undetermined significance/follicular lesion of undetermined significance" of the Bethesda System for Reporting Thyroid Cytopathology using subcategorization and BRAF mutation results.
    Hyeon J; Ahn S; Shin JH; Oh YL
    Cancer Cytopathol; 2014 May; 122(5):368-76. PubMed ID: 24591408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcategorization of atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS): a study applying Thyroid Imaging Reporting and Data System (TIRADS).
    Yoon JH; Kwon HJ; Kim EK; Moon HJ; Kwak JY
    Clin Endocrinol (Oxf); 2016 Aug; 85(2):275-82. PubMed ID: 26639612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategy to reduce unnecessary surgeries in thyroid nodules with cytology of Bethesda category III (AUS/FLUS): a retrospective analysis of 667 patients diagnosed by surgery.
    Suh YJ; Choi YJ
    Endocrine; 2020 Sep; 69(3):578-586. PubMed ID: 32297204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Parameter for Deciding the BRAFV600E Mutation Test in Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Thyroid Nodules: US Features According to TIRADS.
    Rho M; Kim EK; Moon HJ; Yoon JH; Park VY; Han K; Kwak JY
    Ultrasound Q; 2017 Dec; 33(4):284-288. PubMed ID: 28877096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic values of BRAF(V600E) mutation analysis and Bethesda system for reporting thyroid cytopathology in thyroid nodules with TIRADS 4 and 5].
    Han Y; Zhao BW; Li SY; Lyu JG; Shou JD; Xu HS; Lou HY; Xu LL; Gao L; Xu SX; Zhu J
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Sep; 52(9):686-691. PubMed ID: 28910894
    [No Abstract]   [Full Text] [Related]  

  • 16. Malignancy risk and characteristics of thyroid nodules with two consecutive results of atypia of undetermined significance or follicular lesion of undetermined significance on cytology.
    Park VY; Kim EK; Kwak JY; Yoon JH; Moon HJ
    Eur Radiol; 2015 Sep; 25(9):2601-7. PubMed ID: 25740802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different qualifiers of AUS/FLUS thyroid FNA have distinct BRAF, RAS, RET/PTC, and PAX8/PPARg alterations.
    Bellevicine C; Sgariglia R; Migliatico I; Vigliar E; D'Anna M; Nacchio MA; Serra N; Malapelle U; Bongiovanni M; Troncone G
    Cancer Cytopathol; 2018 May; 126(5):317-325. PubMed ID: 29469940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Value of Six Thyroid Imaging Reporting and Data Systems (TIRADS) in Cytologically Equivocal Thyroid Nodules.
    Słowińska-Klencka D; Wysocka-Konieczna K; Klencki M; Popowicz B
    J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32709122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of diagnostic accuracy of ACR-TIRADS, American Thyroid Association (ATA), and EU-TIRADS guidelines in detecting thyroid malignancy.
    Koc AM; Adıbelli ZH; Erkul Z; Sahin Y; Dilek I
    Eur J Radiol; 2020 Dec; 133():109390. PubMed ID: 33181485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the C-TIRADS, ACR-TIRADS, and ATA guidelines in malignancy risk stratification of thyroid nodules.
    Cai Y; Yang R; Yang S; Lu L; Ma R; Xiao Z; Lin N; Huang Y; Chen L
    Quant Imaging Med Surg; 2023 Jul; 13(7):4514-4525. PubMed ID: 37456322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.